PL3076996T3 - Szczepionka przeciwko cirkowirusowi świń typu 2 - Google Patents

Szczepionka przeciwko cirkowirusowi świń typu 2

Info

Publication number: PL3076996T3
Authority: PL; Poland
Prior art keywords: virus type; vaccine against; against porcine; circo virus; porcine circo
Prior art date: 2013-12-03

Application number

PL14805617T

Other languages

English (en)

Inventor

Vicky Fachinger

Melanie SNO

Maarten Hendrik Witvliet

Original Assignee

Intervet International B.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-12-03

Filing date

2014-12-02

Publication date

2020-05-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49680926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3076996(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-12-02 Application filed by Intervet International B.V. filed Critical Intervet International B.V.

2020-05-18 Publication of PL3076996T3 publication Critical patent/PL3076996T3/pl

Links

241001673669 Porcine circovirus 2 Species 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

PL14805617T 2013-12-03 2014-12-02 Szczepionka przeciwko cirkowirusowi świń typu 2 PL3076996T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP13195515		2013-12-03
PCT/EP2014/076224 WO2015082458A1 (en)	2013-12-03	2014-12-02	Vaccine against porcine circo virus type 2
EP14805617.9A EP3076996B1 (en)	2013-12-03	2014-12-02	Vaccine against porcine circo virus type 2

Publications (1)

Publication Number	Publication Date
PL3076996T3 true PL3076996T3 (pl)	2020-05-18

Family

ID=49680926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14805617T PL3076996T3 (pl)	2013-12-03	2014-12-02	Szczepionka przeciwko cirkowirusowi świń typu 2

Country Status (13)

Country	Link
US (1)	US10130698B2 (pl)
EP (1)	EP3076996B1 (pl)
JP (1)	JP6605469B2 (pl)
KR (1)	KR20160093047A (pl)
CN (2)	CN110354258A (pl)
BR (1)	BR112016012435A8 (pl)
CA (1)	CA2931137C (pl)
DK (1)	DK3076996T3 (pl)
ES (1)	ES2771899T3 (pl)
MX (1)	MX369039B (pl)
PL (1)	PL3076996T3 (pl)
RU (1)	RU2712155C2 (pl)
WO (1)	WO2015082458A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6605469B2 (ja)	2013-12-03	2019-11-13	インターベットインターナショナルベー．フェー．	ブタサーコウイルス２型に対するワクチン
RU2018118175A (ru) *	2015-10-22	2019-11-25	Интервет Интернэшнл Б.В.	Вакцина для защиты mda-позитивного животного от расстройства, возникающего в результате инфекции, вызванной lawsonia intracellularis
EP3432920A1 (en) *	2016-03-23	2019-01-30	Intervet International B.V.	A vaccine for intradermal application against pcv2 and prrs virus infection
EP3609533A1 (en) *	2017-04-13	2020-02-19	Intervet International B.V.	Vaccines containing swine pathogens for associated non-mixed use
WO2022186661A1 (ko) *	2021-03-04	2022-09-09	주식회사 이노백	돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7022328B1 (en)	1995-11-30	2006-04-04	Australian Pork Limited	Therapeutic and diagnostic compositions
FR2781159B1 (fr) *	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US7276353B2 (en)	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
HRP20080235T3 (hr)	2003-07-24	2008-07-31	Merial Limited	Formulacija vakcine koja sadrži emulziju ulje-u-vodi
KR20060134054A (ko)	2004-01-22	2006-12-27	인터벳 인터내셔널 비.브이.	로소니아 인트라셀룰라리스 서브유닛 백신
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7691368B2 (en) *	2005-04-15	2010-04-06	Merial Limited	Vaccine formulations
AU2006289102C1 (en)	2005-09-09	2017-11-30	Intervet International B.V.	PCV-2 vaccine
PL2371383T3 (pl)	2005-12-29	2016-01-29	Boehringer Ingelheim Vetmedica Inc	Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
WO2008073464A2 (en)	2006-12-11	2008-06-19	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
ES2625460T5 (es)	2006-12-15	2020-11-04	Boehringer Ingelheim Animal Health Usa Inc	Tratamiento de cerdos seropositivos en anticuerpo anti-PCV2 con antígeno de PCV2
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
EP2242511A4 (en) *	2008-01-23	2012-10-24	Boehringer Ingelheim Vetmed	IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
TWI449533B (zh)	2008-04-18	2014-08-21	Intervet Int Bv	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅｃｉｒｃｏｖｉｒｕｓ）用疫苗
TWI551295B (zh)	2008-04-18	2016-10-01	英特威特國際股份有限公司	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
UA114504C2 (uk) *	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) *	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
JP6488304B2 (ja)	2013-12-03	2019-03-20	インターベットインターナショナルベー．フェー．	ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン
JP6605469B2 (ja)	2013-12-03	2019-11-13	インターベットインターナショナルベー．フェー．	ブタサーコウイルス２型に対するワクチン

2014
- 2014-12-02 JP JP2016535652A patent/JP6605469B2/ja active Active
- 2014-12-02 BR BR112016012435A patent/BR112016012435A8/pt not_active Application Discontinuation
- 2014-12-02 CN CN201910822557.6A patent/CN110354258A/zh active Pending
- 2014-12-02 ES ES14805617T patent/ES2771899T3/es active Active
- 2014-12-02 DK DK14805617.9T patent/DK3076996T3/da active
- 2014-12-02 CN CN201480066507.5A patent/CN105848675A/zh active Pending
- 2014-12-02 PL PL14805617T patent/PL3076996T3/pl unknown
- 2014-12-02 WO PCT/EP2014/076224 patent/WO2015082458A1/en not_active Ceased
- 2014-12-02 US US15/038,765 patent/US10130698B2/en active Active
- 2014-12-02 MX MX2016007224A patent/MX369039B/es active IP Right Grant
- 2014-12-02 EP EP14805617.9A patent/EP3076996B1/en not_active Revoked
- 2014-12-02 CA CA2931137A patent/CA2931137C/en active Active
- 2014-12-02 RU RU2016126392A patent/RU2712155C2/ru active
- 2014-12-02 KR KR1020167017419A patent/KR20160093047A/ko not_active Ceased

Also Published As

Publication number	Publication date
WO2015082458A1 (en)	2015-06-11
CN105848675A (zh)	2016-08-10
US20170157236A1 (en)	2017-06-08
BR112016012435A2 (pt)	2017-08-08
BR112016012435A8 (pt)	2018-01-30
EP3076996B1 (en)	2020-01-15
KR20160093047A (ko)	2016-08-05
MX2016007224A (es)	2016-07-21
ES2771899T3 (es)	2020-07-07
US10130698B2 (en)	2018-11-20
CN110354258A (zh)	2019-10-22
RU2712155C2 (ru)	2020-01-24
DK3076996T3 (en)	2020-03-09
MX369039B (es)	2019-10-25
JP6605469B2 (ja)	2019-11-13
EP3076996A1 (en)	2016-10-12
JP2017501984A (ja)	2017-01-19
CA2931137C (en)	2023-03-14
CA2931137A1 (en)	2015-06-11

Publication	Publication Date	Title
IL276210A (en)	2020-09-30	MERS-COV vaccine
IL279395A (en)	2021-01-31	A vaccine
SG11201507883SA (en)	2015-10-29	Wt1-antigen peptide conjugate vaccine
PL3077519T3 (pl)	2021-10-18	Szczepionki CMV
GB201321242D0 (en)	2014-01-15	Immunogenic compound
PT2806891T (pt)	2019-07-01	Vacinas baseadas no vírus parainfluenza 5
EP2974740A4 (en)	2016-08-24	HEPATITIS B VACCINE
GB201304837D0 (en)	2013-05-01	Implant trialling
IL241271A0 (en)	2015-11-30	Pertussis vaccine
GB201301085D0 (en)	2013-03-06	Glycoconjugate Vaccine
GB201304835D0 (en)	2013-05-01	Implant trialling
SG11201510617WA (en)	2016-01-28	Methods and compositions for dengue virus vaccines
PL3076996T3 (pl)	2020-05-18	Szczepionka przeciwko cirkowirusowi świń typu 2
SG11201505930TA (en)	2015-08-28	Porcine parvovirus 5b, methods of use and vaccine
PL2958935T3 (pl)	2020-03-31	Szczepionka
ZA201507770B (en)	2017-02-22	Composition with reduced immunogenicity
EP2968394A4 (en)	2016-04-20	NEW VACCINES AGAINST MULTIPLE SUBTYPES OF THE DENGUE VIRUS
GB201301119D0 (en)	2013-03-06	Viral vaccines
SG11201507455WA (en)	2015-10-29	Hepatitis b virus vaccines
TWM475510U (en)	2014-04-01	Radical engine
ZA201506581B (en)	2021-09-29	Acellular pertussis vaccine
GB201314063D0 (en)	2013-09-18	Virus
GB201306812D0 (en)	2013-05-29	Virus
GB201320646D0 (en)	2014-01-08	Vaccine
GB201315556D0 (en)	2013-10-16	Vaccine